(1)Effects of Atractylodes Oil on Inflammatory Response and Serum Metabolites in Adjuvant Arthritis Rats.[J] .Biomed Pharmacother, 2020, 127: 110130. (共一作者)
(2)Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.[J].Eur J Clin Pharmacol, 2021.1.29. (通讯作者)
(3)Endothelial Conditional Knockdown of NMMHC IIA (Nonmuscle Myosin Heavy Chain IIA) Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury.[J] .Stroke, 2021, 52: 1053-1064.(共一作者)
(4)Atractylodin Attenuates Dextran Sulfate Sodium-induced Colitis by Alleviating Gut Microbiota Dysbiosis and Inhibiting Inflammatory Response Through the MAPK Pathway[J] .Front Pharmacol, 2021,4: 665376.(通讯作者)
(5)A novel lurasidone hydrochloride–shikimic acid co-amorphous system formed by hydrogen-bonding interaction with the retained pH-dependent solubility behavior[J].CrystEngComm, 2020, 22, 5841-5853. (通讯作者)
(6)YiQiFuMai powder injection ameliorates blood–brain barrier dysfunction and brain edema after focal cerebral ischemia–reperfusion injury in mice. Drug Design Development & Therapy, 2016, 10: 315-325.(第一作者)
(7)Ruscogenin Attenuates Cerebral Ischemia-Induced Blood-Brain Barrier Dysfunction by Suppressing TXNIP/NLRP3 Inflammasome Activation and the MAPK Pathway. International Journal of Molecular Sciences, 2016, 17(9): 1418.(第一作者)
(8)YiQiFuMai Powder Injection ameliorates the oxygen-glucose deprivation-induced brain microvascular endothelial barrier dysfunction associated with the NF-κB and ROCK1/MLC signaling pathways. Journal of Ethnopharmacology, 2016, 183: 18-28.(第一作者)
(9)YiQiFuMai Powder Injection Ameliorates Cerebral Ischemia by Inhibiting Endoplasmic Reticulum Stress-Mediated Neuronal Apoptosis. Oxidative Medicine and Cellular Longevity, 2016, (2016): 5493279.(第一作者)
(10)A combination of four effective components derived from Sheng-mai san attenuates hydrogen peroxide-induced injury in PC12 cells linked with inhibiting Akt and MAPKs signaling pathways. Chinese Journal of Natural Medicines, 2016, 14(7):508-517.(第一作者)